EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA ...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis - Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted ...

The scientists supposedly all had access to sensitive government research, and the nature of their work has led to ...

As Health Secretary Robert F. Kennedy Jr. prepares to wean the country off mental health medications, U.S. Health Department ...

The BC Conservation & Biodiversity Awards are pleased to announce the 2026 Award recipients, recognizing 20 outstanding conservation initiatives working to protect and restore BC's natural environment ...

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first quarter of 2026 and recent weeks included ...

In April 2026, BioAge reported positive topline data from the Phase 1 trial of BGE-102, its oral, brain-penetrant NLRP3 inhibitor, including a newly announced 60 mg once-daily cohort in participants ...

The opening of the new documentary about the loud, hilarious and irreverent ’90’s band the Lunachicks features the same kinds ...

With cutting-edge sports medicine and sci-fi gadgetry, more and more athletes are figuring out how to extend their careers.

A red barn is seen on a rural road on April 21, 2026, in Rossville, Ind. | Jamie Kelter Davis for POLITICO I’m not the only ...

A whopping 2.7 million voters have been deleted from the electoral rolls in West Bengal after the controversial SIR exercise.

Before Lerone Martin joined Stanford in 2022 as director of the Martin Luther King Jr. Research and Education Institute, he ...